279 related articles for article (PubMed ID: 29051008)
1. DNA recombination defects in Kuwait: Clinical, immunologic and genetic profile.
Al-Herz W; Massaad MJ; Chou J; Notarangelo LD; Geha RS
Clin Immunol; 2018 Feb; 187():68-75. PubMed ID: 29051008
[TBL] [Abstract][Full Text] [Related]
2. Human RAG mutations: biochemistry and clinical implications.
Notarangelo LD; Kim MS; Walter JE; Lee YN
Nat Rev Immunol; 2016 Apr; 16(4):234-46. PubMed ID: 26996199
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of naturally occurring DCLRE1C mutations and correlation with the clinical phenotype of ARTEMIS deficiency.
Felgentreff K; Lee YN; Frugoni F; Du L; van der Burg M; Giliani S; Tezcan I; Reisli I; Mejstrikova E; de Villartay JP; Sleckman BP; Manis J; Notarangelo LD
J Allergy Clin Immunol; 2015 Jul; 136(1):140-150.e7. PubMed ID: 25917813
[TBL] [Abstract][Full Text] [Related]
4. The Clinical and Genetic Spectrum of 82 Patients With
Sharapova SO; Skomska-Pawliszak M; Rodina YA; Wolska-Kuśnierz B; Dabrowska-Leonik N; Mikołuć B; Pashchenko OE; Pasic S; Freiberger T; Milota T; Formánková R; Szaflarska A; Siedlar M; Avčin T; Markelj G; Ciznar P; Kalwak K; Kołtan S; Jackowska T; Drabko K; Gagro A; Pac M; Naumova E; Kandilarova S; Babol-Pokora K; Varabyou DS; Barendregt BH; Raykina EV; Varlamova TV; Pavlova AV; Grombirikova H; Debeljak M; Mersiyanova IV; Bondarenko AV; Chernyshova LI; Kostyuchenko LV; Guseva MN; Rascon J; Muleviciene A; Preiksaitiene E; Geier CB; Leiss-Piller A; Yamazaki Y; Kawai T; Walter JE; Kondratenko IV; Šedivá A; van der Burg M; Kuzmenko NB; Notarangelo LD; Bernatowska E; Aleinikova OV
Front Immunol; 2020; 11():900. PubMed ID: 32655540
[No Abstract] [Full Text] [Related]
5. Long-Term Health Outcome and Quality of Life Post-HSCT for IL7Rα-, Artemis-, RAG1- and RAG2-Deficient Severe Combined Immunodeficiency: a Single Center Report.
Abd Hamid IJ; Slatter MA; McKendrick F; Pearce MS; Gennery AR
J Clin Immunol; 2018 Aug; 38(6):727-732. PubMed ID: 30105620
[TBL] [Abstract][Full Text] [Related]
6. A Novel Non-Coding Variant in DCLRE1C Results in Deregulated Splicing and Induces SCID Through the Generation of a Truncated ARTEMIS Protein That Fails to Support V(D)J Recombination and DNA Damage Repair.
Strubbe S; De Bruyne M; Pannicke U; Beyls E; Vandekerckhove B; Leclercq G; De Baere E; Bordon V; Vral A; Schwarz K; Haerynck F; Taghon T
Front Immunol; 2021; 12():674226. PubMed ID: 34220820
[TBL] [Abstract][Full Text] [Related]
7. Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.
Walter JE; Rosen LB; Csomos K; Rosenberg JM; Mathew D; Keszei M; Ujhazi B; Chen K; Lee YN; Tirosh I; Dobbs K; Al-Herz W; Cowan MJ; Puck J; Bleesing JJ; Grimley MS; Malech H; De Ravin SS; Gennery AR; Abraham RS; Joshi AY; Boyce TG; Butte MJ; Nadeau KC; Balboni I; Sullivan KE; Akhter J; Adeli M; El-Feky RA; El-Ghoneimy DH; Dbaibo G; Wakim R; Azzari C; Palma P; Cancrini C; Capuder K; Condino-Neto A; Costa-Carvalho BT; Oliveira JB; Roifman C; Buchbinder D; Kumanovics A; Franco JL; Niehues T; Schuetz C; Kuijpers T; Yee C; Chou J; Masaad MJ; Geha R; Uzel G; Gelman R; Holland SM; Recher M; Utz PJ; Browne SK; Notarangelo LD
J Clin Invest; 2015 Nov; 125(11):4135-48. PubMed ID: 26457731
[TBL] [Abstract][Full Text] [Related]
8. RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production.
Min Q; Meng X; Zhou Q; Wang Y; Li Y; Lai N; Xiong E; Wang W; Yasuda S; Yu M; Zhang H; Sun J; Wang X; Wang JY
JCI Insight; 2021 Oct; 6(19):. PubMed ID: 34622798
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity in RAG1 and RAG2 deficiency: 35 cases from a single-centre.
Karaatmaca B; Cagdas D; Esenboga S; Erman B; Tan C; Turul Ozgur T; Boztug K; van der Burg M; Sanal O; Tezcan I
Clin Exp Immunol; 2024 Feb; 215(2):160-176. PubMed ID: 37724703
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.
Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL
J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155
[TBL] [Abstract][Full Text] [Related]
11. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
12. Two siblings with PRKDC defect who presented with cutaneous granulomas and review of the literature.
Esenboga S; Akal C; Karaatmaca B; Erman B; Dogan S; Orhan D; Boztug K; Ayvaz D; Tezcan İ
Clin Immunol; 2018 Dec; 197():1-5. PubMed ID: 30121298
[TBL] [Abstract][Full Text] [Related]
13. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
[TBL] [Abstract][Full Text] [Related]
14. The many faces of Artemis-deficient combined immunodeficiency - Two patients with DCLRE1C mutations and a systematic literature review of genotype-phenotype correlation.
Lee PP; Woodbine L; Gilmour KC; Bibi S; Cale CM; Amrolia PJ; Veys PA; Davies EG; Jeggo PA; Jones A
Clin Immunol; 2013 Dec; 149(3):464-74. PubMed ID: 24230999
[TBL] [Abstract][Full Text] [Related]
15. Vasculitis as a Major Morbidity Factor in Patients With Partial RAG Deficiency.
Geier CB; Farmer JR; Foldvari Z; Ujhazi B; Steininger J; Sleasman JW; Parikh S; Dilley MA; Pai SY; Henderson L; Hazen M; Neven B; Moshous D; Sharapova SO; Mihailova S; Yankova P; Naumova E; Özen S; Byram K; Fernandez J; Wolf HM; Eibl MM; Notarangelo LD; Calabrese LH; Walter JE
Front Immunol; 2020; 11():574738. PubMed ID: 33193364
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-lymphocyte-associated protein 4-Ig effectively controls immune activation and inflammatory disease in a novel murine model of leaky severe combined immunodeficiency.
Humblet-Baron S; Schönefeldt S; Garcia-Perez JE; Baron F; Pasciuto E; Liston A
J Allergy Clin Immunol; 2017 Nov; 140(5):1394-1403.e8. PubMed ID: 28185879
[TBL] [Abstract][Full Text] [Related]
17. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
18. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
19. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
20. Compound heterozygous DCLRE1C mutations lead to clinically typical Severe Combined Immunodeficiency presenting with Graft Versus Host Disease.
Mou W; Gao L; He J; Yin J; Xu B; Gui J
Immunogenetics; 2021 Dec; 73(6):425-434. PubMed ID: 34406419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]